Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Various treatments exist for hair loss, but more research is needed for better options.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Balding men had lower bone density, while balding women had higher hip bone density.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.